Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as analysts said resumption of U.S. shipments for ...

While Sarepta has now consented to the FDA’s request to stop selling Elevidys, the company’s brief standoff with the agency ...

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after ...

Sarepta Therapeutics SRPT -2.17% is restructuring, laying off 36% of its workforce and making changes to its executive team. The restructuring is expected to save $400 million a year, the gene ...

Sarepta Therapeutics Inc. shares soared after the company said it was cutting more than a third of its workforce and that its gene therapy for a fatal muscle disorder would stay on the market with ...

OpenAI has officially added Google Cloud to its list of infrastructure providers, joining a growing lineup that includes Microsoft Azure, Oracle, and CoreWeave. The move, confirmed on OpenAIs ...

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are soaring in Wednesday’s after-hours session after the company announced a strategic restructuring and cost-cutting measures. What To Know: After ...

Newsom blasts Trump over partial National Guard withdrawal California governor says federal drawdown does little to calm fear in immigrant communities after weeks of aggressive ICE operations.

By Katherine Hamilton Sarepta Therapeutics is restructuring, laying off 36% of its workforce and making changes to its executive team.